Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Introduction Acute poisoning in children is still a global health concern that necessitates visiting the emergency department that might associated with morbidity and mortality. It has an impact on social, economic, and health issues, particularly for children under five who account for the majority of poisonings worldwide. Poisoning can result in mild cases, serious complications, or even death; oral ingestion is the most common way that poisoning occurs in children.
View Article and Find Full Text PDFMicrobial Treatment Targets for Potable and Nonpotable Water Reuse - A Comprehensive Update and Harmonization.
Environ Sci Technol Lett
October 2024
Soller Environmental, Berkeley, California 94703, United States.
Increasing pressures on traditional sources of water have accelerated the adoption of water reuse throughout the world. A key consideration for communities pursuing water reuse is understanding the amount of treatment that is needed to ensure adequate human health protection. Several U.
View Article and Find Full Text PDFPractical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Cancer
February 2025
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, Maryland, USA.
Tarlatamab is a bispecific T-cell engager immunotherapy targeting delta-like ligand 3 (DLL3) and the cluster of differentiation 3 (CD3) molecule. In the phase 2 DeLLphi-301 trial of tarlatamab for patients with previously treated small cell lung cancer, tarlatamab 10 mg every 2 weeks achieved durable responses and encouraging survival outcomes. Analyses of updated safety data from the DeLLphi-301 trial demonstrated that the most common treatment-emergent adverse events were cytokine release syndrome (53%), pyrexia (38%), decreased appetite (36%), dysgeusia (32%), and an emia (30%).
View Article and Find Full Text PDFUndesignated Glucagon in Schools for the Treatment of Diabetes-Related Hypoglycemia: A 2025 Update.
NASN Sch Nurse
January 2025
Medical Writer/Sole Proprietor, K-File Medical Writing and Editing Services, LLC, Chicago, IL.
Hypoglycemia will occur on school grounds in students with diabetes who are receiving glucose-lowering drugs. Hypoglycemia may be severe, in which a student is unconscious or comatose. Fast-acting carbohydrates remain the first line of treatment for nonsevere hypoglycemia but preparedness with emergency injectable or intranasal glucagon is ideal.
View Article and Find Full Text PDFExploring factors of physicians' preferences for continuing medical education.
BMC Med Educ
November 2024
Faculty of Health Sciences, Bielefeld University, Bielefeld, Germany.
Background: Achieving sustainability in continuing medical education (CME) involves regular assessment of the evolving needs of healthcare professionals regarding their competencies and updates in educational content accordingly. This study aimed to investigate the key areas and competencies that physicians in Serbia prioritize for their professional development and to analyze the factors associated with these competencies.
Method: This cross-sectional study was conducted among 2,625 physicians who are members of the medical chamber in Serbia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!